Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma
Clinical trial NCT05076786 · UNKNOWN
Trial details
- NCT number
- NCT05076786
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-27
- Primary completion
- 2022-10-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.